We are on the verge of major changes in biotechnology, from the way innovation is carried out to the types of problems we are poised to solve. Can we imagine a world without cancer? Or a world in which medical treatments are more tailored to our individual needs?

Technological innovation is exploding into full view across the life sciences. Together, we will dive deep into new scientific developments in aging research, think about the societal and ethical implications of living longer lives, as well as discuss investment strategies to leverage the opportunities.

11:00 am (CET) Welcome & Introduction

Dr. Christian Schütz (Partner btov), Sabrina Stöckl (Associate btov)

11:10 am R&D today, current perspective and glimpse into the future | Keynote

Dr. Danny Bar-Zohar (Global Head of Development Merck Group)

11:40 am Aiming for longevity: It’s about a healthy lifespan not an endless lifespan | Keynote

Dr. Christian Schütz (Partner btov)

12:00 pm Restoring and maintaining our biological age at optimal performance | Keynote

Prof. Dr. Evelyne Bischof (Prof of medicine, chief physician internal medicine, longevity physician at Human Longevity)

12:20 pm Longevity in the era of AI driven medicine | Panel

Prof. Dr. Evelyne Bischof, Dr. Alex Zhavoronkov (Founder & CEO Insilico Medicine)

Moderator: Sabrina Stöckl (Associate btov)

1:00 pm Lunch

2:30 pm The future of health | Key note

James Morgon (Senior Advisor Milken Institute)

2:50 pm Early diagnostics – how to beat cancer in the next 10 years? | Fireside chat

Sarah Kerruish (Chief Strategy Offer Kheiron Medical), Dr. Christian Schütz (Partner btov)

3:10 pm Learning to learn – The power of Machine Learning in drug design | Scientific deepdive 

Prof. Dr. Ross King (Research Director University of Cambridge, Department for Chemical Engineering and Biotechnology)

3:30 pm Break

4:10 pm Brain health technologies to cure neurodegenerative diseases | Panel

Ofer Leidner (Co-Founder & President Happify Health), Dr. Nawal Roy (Founder & CEO Holmusk), Travis Bond (CEO Altoida)

Moderator: Jan-Hendrik Buerk (Partner btov)

4:40 pm The importance of our gut microbiome | Fireside chat

Dr. Markus Rinecker (Co-Founder mbiomics), Constantin Schwaab (Serial entrepreneur and btov Private Investor)

5:00 pm Break

5:20 pm European Big Pharma – Trends & Developments | Key note

Michael Leuchten (Head of EU Pharmaceutical Research UBS)

5:40 pm Funding gaps in Europe – How can European biotechs achieve greater scale in a fragmented landscape? | Key note

Dr. Alexandra Zemp (Partner McKinsey, Leader of McKinsey’s biotech practice in Europe)

6:00 pm Longevity: Why and where to invest? | Panel 

Dr. Alexandra Bause (Partner Apollo Health Ventures), Dr. Neha Tanna (Partner Ordway Selections), Dr. Pooja Sikka (Venture Partner Apex Ventures)

Moderator: Gerrit Jurilj (Partner btov)

6:30 pm Break

7:30 pm Longevity as leadership principle – Fireside chat with surprise guest

8:15 pm Dinner with Speech

Sonia Gössi (Head Wealth Management UBS)

9:45 pm Open Bar

9:00 am Extended Networking Breakfast

10:30 am Bus shuttle to START Summit (University of St.Gallen)

Agenda and speakers are subject to change.

For press related questions, please contact chase.gummer@btov.vc